Time to Achieve Blood Pressure Goal with a Combination Versus a Conventional Monotherapy Approach in Hypertensive Patients with Metabolic Syndrome

2010 ◽  
Vol 32 (5) ◽  
pp. 245-250 ◽  
Author(s):  
Roberto Fogari ◽  
Annalisa Zoppi ◽  
Ilaria Ferrari ◽  
Amedeo Mugellini ◽  
Paola Preti ◽  
...  
2007 ◽  
Vol 12 (6) ◽  
pp. 351-356 ◽  
Author(s):  
Gregory P. Vyssoulis ◽  
Eva A. Karpanou ◽  
Stella-Maria G. Kyvelou ◽  
Dionysios N. Adamopoulos ◽  
Alexandros D. Deligeorgis ◽  
...  

2012 ◽  
Vol 35 (6) ◽  
pp. 624-632 ◽  
Author(s):  
Saide Aytekin ◽  
Sema Guneri ◽  
Nese Cam ◽  
Ali Aydinlar ◽  
Guliz Kozdag ◽  
...  

2017 ◽  
Vol 118 ◽  
pp. 53-63 ◽  
Author(s):  
Alexandra Yannoutsos ◽  
Rania Kheder-Elfekih ◽  
Jean-Michel Halimi ◽  
Michel E. Safar ◽  
Jacques Blacher

2007 ◽  
Vol 117 (3) ◽  
pp. 312-316 ◽  
Author(s):  
L. Aldo Ferrara ◽  
Lucio Guida ◽  
Fabio Ferrara ◽  
Giuliano De Luca ◽  
Rosaria Castaldo ◽  
...  

2018 ◽  
Vol 10 (1) ◽  
pp. 41-45
Author(s):  
Stelina Alkagiet ◽  
Konstantinos Tziomalos

Suboptimal adherence to antihypertensive treatment is very common and is associated with poor control of blood pressure and increased risk for cardiovascular events. Therefore, frequent evaluation of compliance is essential in all hypertensive patients. Simplifying treatment regimens, using fixed-dose combinations and long-acting agents improves adherence, facilitates achievement of treatment targets and reduces cardiovascular morbidity and healthcare expenditures. Accordingly, physicians should be educated to implement these changes in hypertensive patients, particularly in those who require multiple antihypertensive agents to achieve blood pressure controls and in those who receive additional medications for comorbidities.


Sign in / Sign up

Export Citation Format

Share Document